These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11968844)

  • 1. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 2. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
    Kaplan DD; Reddy KR
    Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
    Koike K
    J Gastroenterol; 2002; 37(11):988-90. PubMed ID: 12483259
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the optimal therapy for chronic hepatitis B?
    Lyra AC; Di Bisceglie AM
    Minerva Med; 2001 Dec; 92(6):431-4. PubMed ID: 11740431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and clinical course in HBV and HCV dual chronic infection].
    Tamori A; Nishiguchi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):667-70. PubMed ID: 15359882
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R; Lada O; Marcellin P
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
    Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
    J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA
    Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of viral hepatitis].
    Porst H
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():31-2. PubMed ID: 12467003
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of chronic hepatitis B: today and tomorrow.
    Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):689-98. PubMed ID: 14756005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of and current treatment options for hepatitis B and hepatitis C.
    Adams P
    J Can Dent Assoc; 2000 Nov; 66(10):537. PubMed ID: 12584770
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis].
    Friedrich-Rust M; Forestier N; Zeuzem S
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S229-30. PubMed ID: 16435720
    [No Abstract]   [Full Text] [Related]  

  • 17. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Reijnders JG; Janssen HL
    J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy of chronic viral hepatitis B with lamivudine and interferon: better than what?
    Andreani T; Serfaty L; Chazouillères O; Poupon R
    J Hepatol; 2002 Apr; 36(4):572-3; author reply 573. PubMed ID: 11943435
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of lamiduvine-resistant mutant chronic hepatitis B with interferon alpha].
    Pariente A; Tachet A; Poveda JD
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1059-60. PubMed ID: 12483147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.